BASF's lead collagen hybridizing peptide (CHP) candidate significantly reduced damaged collagen and stimulated procollagen I production in a clinical study unveiled at the IFSCC 2026 Congress in Perth, Australia. The supplier paired the read-out with bio-based polysaccharide and bio-inspired extraction research projects. Together, the programme stakes out three distinct claims territory for BASF's beauty-care pipeline.

The headline study zeroes in on CHPs — a new class of bioactive peptides whose mechanism is to recognise and bind to damaged collagen fibrils while reinforcing fibroblast-matrix interactions central to skin regeneration.

What does the CHP clinical read out?

The lead CHP candidate, per BASF, selectively targets altered collagen, stimulates procollagen I production, supports tissue repair processes, and significantly reduces the presence of damaged collagen in skin.

The work sits on an AI-driven molecular modelling backbone, which BASF uses to identify binding affinity and selectivity signatures before bench verification. The modelling also shortens peptide screening cycles, a useful efficiency gain for teams working under compressed development timelines.

For formulation teams, the differentiator is selectivity. Generic matrikines and signal peptides also act on intact collagen structures. CHPs are designed around damaged-fibril recognition, supporting claims on visible aging, structural repair and fibroblast-matrix communication.

What does the Stanford polysaccharide film work change?

In a joint project with Stanford University, BASF researchers probed how bio-based polysaccharides form functional films on the skin and influence hydration, barrier properties and overall formulation performance.

The team mapped how molecular entanglement and crystallisation of biopolymers drive film formation and regulate water transport through the stratum corneum. Key read-outs from the study:

• Polysaccharide additives improve hydration retention
• Films facilitate emollient penetration
• Films reduce drying-induced stress
• Skin barrier function remains intact

For moisturiser R&D, the data supply a defined mechanism. Entanglement and crystallisation of biopolymers produce a reservoir film that controls water flux. Formulators can tether that mechanism to claims on 24-hour hydration, barrier resilience and post-cleansing comfort.

Sensory work will need to track the efficacy data: a film that lifts hydration but leaves a tacky or stiff skin feel will not survive consumer review.

Why coconut water as an extraction solvent?

On the podium, Nicole Lv — technical key account manager at BASF Beauty Care Solutions, APAC — introduced a plant-water extraction platform that swaps conventional organic solvents for naturally derived ones.

Lv's team used coconut water as the primary extraction medium and recorded significant increases in polyphenol content across multiple botanical sources. The platform enriched:

• Rose extracts in flavonol glycosides
• Citrus extracts in flavanone glycosides

Coconut-water-extracted actives also delivered measurable improvements in epidermal cohesion and barrier resilience in the team's testing.

For procurement and sustainability leads, the read-across is direct: coconut water offers an INCI-friendly, food-grade solvent that lifts polyphenol yield while cutting reliance on ethanol or butylene glycol in extraction.

For brand owners, the platform supplies a credible sustainability claim — bio-derived solvent, bio-derived actives — backed by compositional fingerprint data.

Where the BASF programme heads next

BASF did not publish a commercialisation timeline for the lead CHP candidate, the polysaccharide film platform or the coconut-water extraction method in Perth. The next milestones R&D and procurement teams will watch:

• Regulatory dossier publication for the lead CHP
• Multi-polysaccharide film efficacy read-outs
• Scale-up data on coconut-water sourcing at cosmetic grade
• Comparative benchmarks against incumbent peptide, humectant and green-solvent actives

Formulators and buyers will, in the meantime, weigh the Perth findings against the peptide, humectant and bio-extract benchmarks already sitting on their ingredient shelves.